
Herbert Goldstein
Examiner (ID: 18423)
| Most Active Art Unit | 2608 |
| Art Unit(s) | 2607, 2403, 2616, 2613, 2214, 2605, 2611, 2608 |
| Total Applications | 1485 |
| Issued Applications | 1358 |
| Pending Applications | 2 |
| Abandoned Applications | 125 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20187273
[patent_doc_number] => 12398380
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-26
[patent_title] => Methods of host cell modification
[patent_app_type] => utility
[patent_app_number] => 17/541454
[patent_app_country] => US
[patent_app_date] => 2021-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 38338
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17541454
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/541454 | Methods of host cell modification | Dec 2, 2021 | Issued |
Array
(
[id] => 18879062
[patent_doc_number] => 20240002431
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => METHODS OF MAKING AND USING PLATFORMS FOR PEPTIDE SYNTHESIS AND COMPOSITIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/253986
[patent_app_country] => US
[patent_app_date] => 2021-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4534
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18253986
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/253986 | METHODS OF MAKING AND USING PLATFORMS FOR PEPTIDE SYNTHESIS AND COMPOSITIONS THEREOF | Nov 22, 2021 | Pending |
Array
(
[id] => 17830420
[patent_doc_number] => 20220267724
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => GENERATION OF NEURAL STEM CELLS FROM HUMAN TROPHOBLAST STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 17/532385
[patent_app_country] => US
[patent_app_date] => 2021-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38733
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17532385
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/532385 | Generation of neural stem cells from human trophoblast stem cells | Nov 21, 2021 | Issued |
Array
(
[id] => 18902668
[patent_doc_number] => 20240018153
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => BENZENESULFONAMIDE DERIVATIVES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/253730
[patent_app_country] => US
[patent_app_date] => 2021-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50039
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -67
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18253730
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/253730 | BENZENESULFONAMIDE DERIVATIVES AND USES THEREOF | Nov 17, 2021 | Pending |
Array
(
[id] => 18879067
[patent_doc_number] => 20240002436
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => RESPIRATORY TREATMENTS
[patent_app_type] => utility
[patent_app_number] => 18/036382
[patent_app_country] => US
[patent_app_date] => 2021-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14131
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18036382
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/036382 | RESPIRATORY TREATMENTS | Nov 14, 2021 | Pending |
Array
(
[id] => 18830834
[patent_doc_number] => 20230399359
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-14
[patent_title] => TETRAPEPTIDES, COMPOSITIONS COMPRISING THEM, AND THEIR COSMETIC USE
[patent_app_type] => utility
[patent_app_number] => 18/035860
[patent_app_country] => US
[patent_app_date] => 2021-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7142
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18035860
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/035860 | TETRAPEPTIDES, COMPOSITIONS COMPRISING THEM, AND THEIR COSMETIC USE | Nov 14, 2021 | Pending |
Array
(
[id] => 19209551
[patent_doc_number] => 11998586
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-04
[patent_title] => Compositions comprising antimicrobial peptides
[patent_app_type] => utility
[patent_app_number] => 17/525344
[patent_app_country] => US
[patent_app_date] => 2021-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 13
[patent_no_of_words] => 13603
[patent_no_of_claims] => 66
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17525344
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/525344 | Compositions comprising antimicrobial peptides | Nov 11, 2021 | Issued |
Array
(
[id] => 18860266
[patent_doc_number] => 20230414700
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => TG2 INHIBITORS FOR IMPROVING MUCOCILIARY CLEARANCE IN RESPIRATORY DISEASES
[patent_app_type] => utility
[patent_app_number] => 18/031251
[patent_app_country] => US
[patent_app_date] => 2021-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6707
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18031251
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/031251 | TG2 INHIBITORS FOR IMPROVING MUCOCILIARY CLEARANCE IN RESPIRATORY DISEASES | Oct 13, 2021 | Pending |
Array
(
[id] => 18860265
[patent_doc_number] => 20230414699
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => TREATMENT OF DERMATOLOGICAL CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 18/248137
[patent_app_country] => US
[patent_app_date] => 2021-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6861
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18248137
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/248137 | TREATMENT OF DERMATOLOGICAL CONDITIONS | Oct 7, 2021 | Pending |
Array
(
[id] => 19551077
[patent_doc_number] => 12134776
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-05
[patent_title] => Development of optimized recombinant expression construct
[patent_app_type] => utility
[patent_app_number] => 17/495233
[patent_app_country] => US
[patent_app_date] => 2021-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5485
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17495233
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/495233 | Development of optimized recombinant expression construct | Oct 5, 2021 | Issued |
Array
(
[id] => 18784808
[patent_doc_number] => 20230372450
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-23
[patent_title] => METHOD FOR PREPARING A COMPOSITION COMPRISING AN UNFOLDED PROTEIN
[patent_app_type] => utility
[patent_app_number] => 18/030352
[patent_app_country] => US
[patent_app_date] => 2021-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5794
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18030352
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/030352 | METHOD FOR PREPARING A COMPOSITION COMPRISING AN UNFOLDED PROTEIN | Oct 4, 2021 | Pending |
Array
(
[id] => 17370347
[patent_doc_number] => 20220025399
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => ADENO-ASSOCIATED VIRUS (AAV) SEROTYPE 8 SEQUENCES, VECTORS CONTAINING SAME, AND USES THEREFOR
[patent_app_type] => utility
[patent_app_number] => 17/492229
[patent_app_country] => US
[patent_app_date] => 2021-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20623
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17492229
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/492229 | Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor | Sep 30, 2021 | Issued |
Array
(
[id] => 18901397
[patent_doc_number] => 20240016882
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => AUTOPHAGY-INHIBITING PEPTIDE AND ORGANIC ACID SALT THEREOF ADDRESSING ISSUES OF VASCULAR PERMEABILITY
[patent_app_type] => utility
[patent_app_number] => 18/029174
[patent_app_country] => US
[patent_app_date] => 2021-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24347
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18029174
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/029174 | AUTOPHAGY-INHIBITING PEPTIDE AND ORGANIC ACID SALT THEREOF ADDRESSING ISSUES OF VASCULAR PERMEABILITY | Sep 28, 2021 | Pending |
Array
(
[id] => 18895196
[patent_doc_number] => 20240010681
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-11
[patent_title] => PEPTIDES AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 18/029206
[patent_app_country] => US
[patent_app_date] => 2021-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32236
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18029206
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/029206 | PEPTIDES AND METHODS OF USE | Sep 26, 2021 | Pending |
Array
(
[id] => 17336491
[patent_doc_number] => 20220002822
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => CELL LINES EXPRESSING INSERTED SECRETABLE REPORTER GENES AT MULTIPLE STAGES OF DIFFERENTIATION
[patent_app_type] => utility
[patent_app_number] => 17/447974
[patent_app_country] => US
[patent_app_date] => 2021-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5649
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17447974
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/447974 | CELL LINES EXPRESSING INSERTED SECRETABLE REPORTER GENES AT MULTIPLE STAGES OF DIFFERENTIATION | Sep 16, 2021 | Abandoned |
Array
(
[id] => 18716535
[patent_doc_number] => 11793857
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-24
[patent_title] => Hard tissue therapeutics
[patent_app_type] => utility
[patent_app_number] => 17/477918
[patent_app_country] => US
[patent_app_date] => 2021-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 16
[patent_no_of_words] => 20614
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17477918
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/477918 | Hard tissue therapeutics | Sep 16, 2021 | Issued |
Array
(
[id] => 17482138
[patent_doc_number] => 20220089642
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => Fc Receptor-ACE2 Conjugates and Use Thereof
[patent_app_type] => utility
[patent_app_number] => 17/478824
[patent_app_country] => US
[patent_app_date] => 2021-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19658
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17478824
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/478824 | Fc Receptor-ACE2 Conjugates and Use Thereof | Sep 16, 2021 | Abandoned |
Array
(
[id] => 18628536
[patent_doc_number] => 20230287402
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => TWO COMPONENT CO-ASSEMBLING TWO DIMENSIONAL PROTEIN STRUCTURES
[patent_app_type] => utility
[patent_app_number] => 18/040684
[patent_app_country] => US
[patent_app_date] => 2021-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29636
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18040684
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/040684 | TWO COMPONENT CO-ASSEMBLING TWO DIMENSIONAL PROTEIN STRUCTURES | Aug 22, 2021 | Abandoned |
Array
(
[id] => 19537730
[patent_doc_number] => 12130281
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-29
[patent_title] => Gene editing through microfluidic delivery
[patent_app_type] => utility
[patent_app_number] => 17/404286
[patent_app_country] => US
[patent_app_date] => 2021-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 75
[patent_figures_cnt] => 14
[patent_no_of_words] => 20224
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17404286
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/404286 | Gene editing through microfluidic delivery | Aug 16, 2021 | Issued |
Array
(
[id] => 18181597
[patent_doc_number] => 20230042326
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => SKIN SOOTHING COMPOSITION INCLUDING EXOSOMES DERIVED FROM NATURAL EXTRACT
[patent_app_type] => utility
[patent_app_number] => 17/382855
[patent_app_country] => US
[patent_app_date] => 2021-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6704
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17382855
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/382855 | SKIN SOOTHING COMPOSITION INCLUDING EXOSOMES DERIVED FROM NATURAL EXTRACT | Jul 21, 2021 | Abandoned |